Patents by Inventor Eri Ueno

Eri Ueno has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200302408
    Abstract: The convenience of virtual currency transitions can be improved. The electronic document system 1 includes a plurality of electronic document terminals 20 that are capable to transmit and receive information on a virtual currency to and from each other. The sending electronic document terminal 20 includes an amount input module 220 that receives input of an amount billed in a virtual currency in a predetermined electronic document data 100 and an electronic document data transmitting and receiving module 240 that transmits the electronic document data 100 to a receiving electronic document terminal 20. The receiving electronic document terminal 20 includes an electronic document data transmitting and receiving module 240 that receives the transmitted electronic document data 100 and a payment module 250 that performs a process to pay the amount billed in a virtual currency associated with the electronic document data 100.
    Type: Application
    Filed: March 9, 2017
    Publication date: September 24, 2020
    Inventors: Eri UENO, Katsuma TAKAHASHI, Syouichi HONDA, Nobuhiko SHIBATA
  • Patent number: 9125928
    Abstract: An object of the present invention is to provide an agent for suppressing the formation of skin cells induced by exposure to light such as ultraviolet light. The object is achieved by using a purine nucleic acid for suppressing the formation of abnormal skin cells caused by exposure to light.
    Type: Grant
    Filed: June 24, 2011
    Date of Patent: September 8, 2015
    Assignee: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Mitsuaki Kawamura, Shigeo Shinohara, Fumiki Harano, Akihiro Aoki, Eri Ueno
  • Publication number: 20130090301
    Abstract: An object of the present invention is to provide an agent for suppressing the formation of skin cells induced by exposure to light such as ultraviolet light. The object is achieved by using a purine nucleic acid for suppressing the formation of abnormal skin cells caused by exposure to light.
    Type: Application
    Filed: June 24, 2011
    Publication date: April 11, 2013
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Mitsuaki Kawamura, Shigeo Shinohara, Fumiki Harano, Akihiro Aoki, Eri Ueno